col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


51 Ergebisse       Seite 1

 [1] 
BMJ: BMJ evidence-based medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―20 Post-publication peer review and the identification of methodological and reporting issues in COVID-19 trials: a qualitative study Mauricia Davidson, Christoffer Bruun Korfitsen, Carolina Riveros, Anna Chaimani, Isabelle Boutron
2 [GO] 2024―Jul―31 Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic Arnav Agarwal, Gordon Guyatt
3 [GO] 2024―Apr―17 Bad news: how the media reported on an observational study about cardiovascular outcomes of COVID-19 Camilla Alderighi, Raffaele Rasoini, Rebecca De Fiore, Fabio Ambrosino, Steven Woloshin
4 [GO] 2023―Dez―07 Reliance on the highest-quality studies of Long Covid is appropriate and not evidence of bias Tracy Beth Høeg, Shamez Ladhani, Vinay Prasad
5 [GO] 2023―Dez―07 Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al Thomas R Fanshawe
6 [GO] 2023―Sep―26 How methodological pitfalls have created widespread misunderstanding about long COVID Tracy Beth Høeg, Shamez Ladhani, Vinay Prasad
7 [GO] 2023―Jul―25 Challenges to delivering evidence-based management for long COVID Sasha Peiris, Ariel Izcovich, Pedro Ordunez, Silvana Luciani, Carmen Martinez, Sylvain Aldighieri, Ludovic Reveiz
8 [GO] 2023―Apr―17 In-person schooling is essential even during periods of high transmission of COVID-19 Alasdair Munro, Danilo Buonsenso, Sebastián González-Dambrauskas, Robert C Hughes, Sunil S Bhopal, Pablo Vásquez-Hoyos, et al. (+3)
9 [GO] 2023―Mrz―31 School closures during COVID-19: an overview of systematic reviews Samuel Hume, Samuel Robert Brown, Kamal Ram Mahtani
10 [GO] 2023―Jan―19 Using a journal club to navigate a maze of COVID-19 papers in a front-line hospital service Rachel Wenke, Paulina Stehlik, John Gerrard, Sharon Mickan, David Henry
11 [GO] 2022―Sep―29 Proof of concept: all-virtual guideline development workshops using GRADE during the COVID-19 pandemic Madelin R Siedler, M Hassan Murad, Rebecca L Morgan, Yngve Falck-Ytter, Reem A Mustafa, Shahnaz Sultan, Philipp Dahm
12 [GO] 2022―Jul―19 Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent Trisha Greenhalgh, David Fisman, Danielle J Cane, Matthew Oliver, Chandini Raina Macintyre
13 [GO] 2022―Jun―30 Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study Barbara Clyne, Lisa Hynes, Colette Kirwan, Máire McGeehan, Paula Byrne, Martha Killilea, et al. (+7)
14 [GO] 2022―Apr―15 Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal Omar Dewidar, Tamara Lotfi, Miranda Langendam, Elena Parmelli, Zuleika Saz Parkinson, Karla Solo, et al. (+32)
15 [GO] 2022―Mrz―25 Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies John P A Ioannidis
16 [GO] 2022―Mrz―08 Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines Ella Fassler, Andrew Larkin, Kesavan Rajasekharan Nayar, Howard Waitzkin
17 [GO] 2022―Jan―27 Randomised trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a scoping review Julian Hirt, Perrine Janiaud, Lars G. Hemkens
18 [GO] 2022―Jan―20 Correlation between chest CT and RT-PCR testing in India’s second COVID-19 wave: a retrospective cohort study Vishal Mehta, Divya Jyoti, Rishi Tuhin Guria, Chandra Bhushan Sharma
19 [GO] 2022―Jan―19 Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis Naomi Fujita-Rohwerder, Lars Beckmann, Yvonne Zens, Arpana Verma
20 [GO] 2021―Dez―21 Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses Afolarin Otunla, Karen Rees, Paddy Dennison, Richard Hobbs, Jana Suklan, Ella Schofield, et al. (+3)
21 [GO] 2021―Dez―21 Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic Bethan Swift, Carl Heneghan, Jeffrey Aronson, David Howard, Georgia C Richards
22 [GO] 2021―Okt―28 Should COVID-19 vaccination be mandatory? Juan Victor Ariel Franco
23 [GO] 2021―Aug―20 Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges Maria Popp, Peter Kranke, Patrick Meybohm, Maria-Inti Metzendorf, Nicole Skoetz, Miriam S Stegemann, Stephanie Weibel
24 [GO] 2021―Aug―09 Transparency of COVID-19 vaccine trials: decisions without data Sarah Tanveer, Anisa Rowhani-Farid, Kyungwan Hong, Tom Jefferson, Peter Doshi
25 [GO] 2021―Jun―08 Getting the COVID-19 vaccine as a transplant patient Michael Mittelman
26 [GO] 2021―Jun―03 Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study Rebecca Abbott, Alison Bethel, Morwenna Rogers, Rebecca Whear, Noreen Orr, Liz Shaw, et al. (+2)
27 [GO] 2021―Apr―26 Can shared decision making address COVID-19 vaccine hesitancy? Marie-Anne Durand, Peter Scalia, Glyn Elwyn
28 [GO] 2021―Apr―22 Misleading clinical evidence and systematic reviews on ivermectin for COVID-19 Luis Ignacio Garegnani, Eva Madrid, Nicolás Meza
29 [GO] 2021―Apr―13 Does my patient have SARS-CoV-2 infection? A reminder of clinical probability formulas Steven D Stovitz, Ian Shrier
30 [GO] 2021―Mrz―30 Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases Clara Locher, David Moher, Ioana Alina Cristea, Florian Naudet
31 [GO] 2021―Feb―25 COVID-19 information in news media: room for greater transparency Anisa Rowhani-Farid, Kyungwan Hong
32 [GO] 2021―Jan―29 How to humanise the COVID-19 intensive care units Veronica Rivi, Gabriele Melegari, Johanna M.C. Blom
33 [GO] 2021―Jan―05 SARS-CoV-2 myocarditis: what physicians need to know Arsalan Khalil, Tamara Naneishvili, Neeraj Prasad, James Glancy
34 [GO] 2020―Dez―11 Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil Günther Fink, Nina Orlova-Fink, Tobias Schindler, Sandra Grisi, Ana Paula S Ferrer, Claudia Daubenberger, Alexandra Brentani
35 [GO] 2020―Dez―02 Correlation between the use of statins and COVID-19: what do we know? Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
36 [GO] 2020―Okt―21 Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK? Sandeep Dhanda, Vicki Osborne, Elizabeth Lynn, Saad Shakir
37 [GO] 2020―Okt―19 Information and rational decision-making: explanations to patients and citizens about personal risk of COVID-19 Margaret McCartney, Frank Sullivan, Carl Heneghan
38 [GO] 2020―Okt―01 Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review David Jarrom, Lauren Elston, Jennifer Washington, Matthew Prettyjohns, Kimberley Cann, Susan Myles, Peter Groves
39 [GO] 2020―Sep―30 Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19 Sarah Yang, Allen Li, Ali Eshaghpour, Sofia Ivanisevic, Adrian Salopek, John Eikelboom, M Crowther
40 [GO] 2020―Sep―23 Evaluating the performance of high-sensitivity troponin-T in the emergency department during the COVID-19 pandemic Ali A Alsaad, Ernest Wang, Hong Lee, Mark Lampert, Philip Krause, Carl Tommaso, et al. (+6)
41 [GO] 2020―Sep―15 Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis Preeti Malik, Urvish Patel, Deep Mehta, Nidhi Patel, Raveena Kelkar, Muhammad Akrmah, et al. (+2)
42 [GO] 2020―Sep―03 Asthma and COVID-19: review of evidence on risks and management considerations Jamie Hartmann-Boyce, James Gunnell, Jonny Drake, Afolarin Otunla, Jana Suklan, Ella Schofield, et al. (+4)
43 [GO] 2020―Aug―11 Is there a smoker’s paradox in COVID-19? Muhammad Shariq Usman, Tariq Jamal Siddiqi, Muhammad Shahzeb Khan, Urvish K Patel, Izza Shahid, Jawad Ahmed, et al. (+2)
44 [GO] 2020―Jul―27 Sacubitril, valsartan and SARS-CoV-2 Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
45 [GO] 2020―Jul―14 What is the most appropriate respiratory protection against COVID-19? Nicholas E Burr, Christopher J Black
46 [GO] 2020―Jul―10 COVID-19 and metabolic syndrome: could diet be the key? Maryanne Demasi
47 [GO] 2020―Jul―09 Is clinical effectiveness in the eye of the beholder during the COVID-19 pandemic? José Luis Sandoval, Alex Friedlaender, Alfredo Addeo
48 [GO] 2020―Jul―08 COVID-19 clinical trials: see it big and keep it simple Robbe Saesen, Isabelle Huys
49 [GO] 2020―Jul―08 Making a case for case reports in the age of the pandemic Samuel Smith, Shalisa Maisrikrod, Ashly Vu
50 [GO] 2020―Jun―17 Temperature and COVID-19: India Manas Pratim Roy
51 [GO] 2020―Jun―03 COVID-19 and the US response: accelerating health inequities Nneoma E Okonkwo, Ugochi T Aguwa, Minyoung Jang, Iman A Barré, Kathleen R Page, Patrick S Sullivan, et al. (+2)
 [1] 

51 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec